Logo

Perlegen Awarded NIH Grant for Alzheimer s Disease Whole Genome Study

Sep 13, 2004

NEW YORK, Sept. 13 (GenomeWeb News) - Perlegen Sciences said today that it has been awarded a grant from the National Institute on Aging to conduct a whole-genome association study in order to find the genetic determinants of Alzheimer's disease.

 

According to the company, the study will involve study the use of an oligonucleotide array-based genotyping platform to genotype over 1.5 million single nucleotide polymorphisms across the genome in late-onset Alzheimer's disease patients, as well as controls.

 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.